Eszopiclone | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Eszopiclone
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Eszopiclone

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

36 API Suppliers, 20 USDMF, 3 JDMF, 8 EU WC, 10 NDC API, 18 Listed Suppliers, $ API Reference Price

36 API Suppliers
20 USDMF
3 JDMF
8 EU WC
10 NDC API
18 Listed Suppliers
$ API Reference Price

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

66 FDF Dossiers, 45 FDA Orange Book, 3 Europe, 6 Canada, 12 Listed Dossiers

66 FDF Dossiers
45 FDA Orange Book
3 Europe
6 Canada
12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 1MG, TABLET;ORAL - 2MG, TABLET;ORAL - 3MG

TABLET;ORAL - 1MG
TABLET;ORAL - 2MG
TABLET;ORAL - 3MG

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 2 Seqens, 4 DKSH, 5 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 5 Actylis, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 19 BASF, 1 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 11 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 35 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 16 Roquette, 13 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

64 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 26 Controlled & Modified Release, 24 Direct Compression, 21 Solubilizers, 20 Thickeners and Stabilizers, 20 Granulation, 18 Disintegrants & Superdisintegrants, 14 Film Formers & Plasticizers, 13 Topical, 12 Parenteral, 12 Lubricants & Glidants, 11 Co-Processed Excipients, 7 Emulsifying Agents, 7 Taste Masking, 6 Chewable & Orodispersible Aids, 5 Rheology Modifiers, 5 Empty Capsules, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents

64 Fillers, Diluents & Binders
45 Coating Systems & Additives
26 Controlled & Modified Release
24 Direct Compression
21 Solubilizers
20 Thickeners and Stabilizers
20 Granulation
18 Disintegrants & Superdisintegrants
14 Film Formers & Plasticizers
13 Topical
12 Parenteral
12 Lubricants & Glidants
11 Co-Processed Excipients
7 Emulsifying Agents
7 Taste Masking
6 Chewable & Orodispersible Aids
5 Rheology Modifiers
5 Empty Capsules
5 API Stability Enhancers
5 Coloring Agents
4 Vegetarian Capsules
3 Surfactant & Foaming Agents

DIGITAL CONTENT

15 NEWS #PharmaBuzz

15 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 9 Finished Drug Prices, 7 Annual Reports

2 US Medicaid Prescriptions
9 Finished Drug Prices
7 Annual Reports

MARKET PLACE

5 APIs

5 APIs

PATENTS & EXCLUSIVITIES

3 Health Canada Patents

3 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP, 2 Others

2 USP
2 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 3,241 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 3Sunovion Pharmaceuticals Canada Inc.

filter Patent Reset all filters

3 All

01 32750059

filter Product Reset all filters

3 All

01 3ESZOPICLONE

filter Dosage Reset all filters

3 All

01 3TABLET

filter Exp Date Reset all filters

3 All

01 32030-01-28

Farmak Eszopiclone

Product Main Page

01

Sunovion Pharmaceuticals Can...

Eszopiclone

The Generic Rx Session

Not Confirmed

Sunovion Pharmaceuticals Canada Inc.

Country

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-01-28

Date Granted : 2014-11-18

Eszopiclone

Brand Name : LUNESTA

Patent Number : 2750059

Filing Date : 2010-01-28

Strength per Unit : 1 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-01-28

Date Granted : 2014-11-18

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Sunovion Pharmaceuticals Can...

Eszopiclone

The Generic Rx Session

Not Confirmed

Sunovion Pharmaceuticals Canada Inc.

Country

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-01-28

Date Granted : 2014-11-18

Eszopiclone

Brand Name : LUNESTA

Patent Number : 2750059

Filing Date : 2010-01-28

Strength per Unit : 2 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-01-28

Date Granted : 2014-11-18

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Sunovion Pharmaceuticals Can...

Eszopiclone

The Generic Rx Session

Not Confirmed

Sunovion Pharmaceuticals Canada Inc.

Country

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-01-28

Date Granted : 2014-11-18

Eszopiclone

Brand Name : LUNESTA

Patent Number : 2750059

Filing Date : 2010-01-28

Strength per Unit : 3 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-01-28

Date Granted : 2014-11-18

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!